| Dr Faith Lea Sample, PHARMD | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-0000 | |
| Not Available |
| Full Name | Dr Faith Lea Sample |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477321438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 033.0134550 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Faith Lea Sample, PHARMD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: () - | Dr Faith Lea Sample, PHARMD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-0000 |
News Archive
An international research team led by HKUST has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer's disease (AD) for the first time, with an accuracy level of over 96%.
Low oxygen supply (hypoxia) to vulnerable brain tissue is a major contributor to the risk of death or major disability after severe traumatic brain injury (TBI), reports a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The U.S. Food and Drug Administration today announced a program aimed at facilitating the development of safer, more effective external defibrillators used to treat abnormal heart rhythms through improved design and manufacturing practices. External defibrillators are medical devices designed to diagnose life-threatening abnormal heart rhythms and treat them by delivering electrical energy to the heart to restore its normal rhythm.
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
Three new UCSF studies describe the wide reach of the tobacco industry and its influence on young people, military veterans and national health care reform. The analyses will be published in a special July edition of the American Journal of Public Health titled "Modeling to Advance Tobacco Control Policy."
› Verified 9 days ago
Daeun Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 Farrell St, Burlington, VT 05401 Phone: 802-651-0597 | |
Dr. Kyle Maxwell, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 158 Cherry St, Burlington, VT 05401 Phone: 802-862-1562 | |
Lea Juzek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Shelburne Rd, Burlington, VT 05401 Phone: 802-860-3311 Fax: 802-860-2980 | |
Alan Mccampbell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1127 North Ave Ste 11, Burlington, VT 05408 Phone: 802-862-7752 | |
Hae Ji Yoon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 Shelburne Rd, Burlington, VT 05401 Phone: 802-864-8154 | |
Dr. Sarah Abdalla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 Church St, Burlington, VT 05401 Phone: 803-651-1018 | |
Debra M Gibbs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 S Prospect St, Suite 1413, Burlington, VT 05401 Phone: 802-847-5519 Fax: 802-847-1076 |